CORZ
Research Snapshot
Static fundamentals, valuation context, and investor signals for Core Scientific, Inc./tx (CORZ).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
N/A
ROIC, -141.3% FCF margin
Growth
39.5%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 1.1x current ratio
Superinvestors
1
Top: Howard Marks (3.3%)
Strengths to research
- Revenue compounded at 39.5% over five years.
- Return on equity is strong at 30.0%.
- Debt/equity looks manageable at 0.0x.
Watchouts
- Free cash flow margin is negative at -141.3%.
- Valuation multiples are limited or unavailable.
Annual data: 6 periods
Quarterly data: 21 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for CORZ.
Grade D
34
/ 100
Financial Charts
No financial data available for CORZ (annual).
1 superinvestors own CORZ
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Howard Marks Oaktree Capital Management | 9,350,708 | $140M | 3.25% | 0.0% |